Biotech Investissement Group
A range of integrated & innovative solutions in Biotechnology
Diaclone is a member of the Biotech Investissement group of companies collectively offering Customised Products & Services in the fields of Molecular Biology, Immunology, Protein and Cell Engineering.
Custom services, Biomanufacturing and purification, antibodies, recombinant proteins, plasmids, transfection, hybridoma and cell line development, expression vectors, FastELISA kits
Primary and Secondary Antibodies Anti-species, Isotype controls, custom services, hybridoma development – rat, guinea pig, murine.
Monoclonal antibodies, Cytokines, Chemokines, CD markers, Apoptosis, Bioactive antibodies, ELISA Kits, ELISpot Kits, DIAplex, Bioassays.
Platform for the development of single domain (VHH) antibodies (Llama phage display technology) and a growing portfolio of proprietary detection/imaging molecules directed against targets in disease areas like oncology, age related disease and infectious diseases.